Without Form and Void: Learning the Residual of Bioprocess Scale

We argue that encoding Galileo's Similarity Theories as ML inductive biases is the only way to transform bioprocess scaling from alchemical art into a…

Apr 2 • Simon Barnett and Bauer LeSavage

3

March 2026

The Melting Point

We applied autoresearch to protein thermostability, giving AI agents two levels of freedom pitted against Bayesian optimization, and learned when…

Mar 23 • Frank Gao

9

1

December 2025

On the Foundations of Machine Reasoning

Our effort to imbue machines with human-like cognition is fledgling, leaving today’s AI systems in an uncanny valley. Will they emerge with…

Dec 18, 2025 • Simon Barnett and Bauer LeSavage

9

1

1

Pretraining: The First Scaling Frontier

Modern AI models are built on the idea that increasing data, model size, and compute drives major performance gains. As these features become harder to…

Dec 11, 2025 • Bauer LeSavage and Simon Barnett

16

2

5

September 2025

Neuroinflammation: Rethinking Treatment of Brain Disorders

After years of clinical setbacks and deprioritization in neuro drug development, could targeting the brain’s immune system as a new therapeutic…

Sep 4, 2025 • Bauer LeSavage

18

5

1

June 2025

ASCO 2025: Themes & Takeaways

After attending this year's ASCO conference, we've distilled a list of key concepts spanning checkpoint inhibition, TCR-inspired drugs, tackling…

Jun 18, 2025 • Simon Barnett and Bauer LeSavage

6

Enlicitide: A Curious(er) Macrocycle

Macrocyclic compounds lend themselves to interesting pharmacology. Merck's emerging PCSK9 inhibitor for "bad" cholesterol is no different. Will it…

Jun 13, 2025 • Simon Barnett

6

1

May 2025

Don't Fall in Love with Your Molecule

Technical success doesn't guarantee market success. This essay explores how target product profiles align discovery with demand to build enduring…

May 15, 2025 • Simon Barnett

25

4

3

February 2025

CTRL + ALT + DEPLETE

Resetting a dysfunctional immune system via the selective depletion of rogue cells is an emerging therapeutic strategy, having matured in the oncology…

Feb 24, 2025 • Bauer LeSavage

15

December 2024

NeurIPS 2024 Open Notes

Our team visited Vancouver to attend NeurIPS 2024. These are our initial notes from many of the AI x Biology workshops.

Dec 22, 2024 • Simon Barnett and Bauer LeSavage

10

2

MoML 2024 Open Notes

Our team recently attended the MoML Conference in Boston. We've curated a selection of our notes to push out into the open. Enjoy!

Dec 14, 2024 • Simon Barnett

9

2

4

October 2024

RMC-6236: A Curious Macrocycle

Macrocycles are a potent, intriguing class of therapies that are growing in importance. Revolution Medicines' RMC-6236 is a perfect example.

Oct 11, 2024 • Simon Barnett

8

1